One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Clinical trial NCT02240121 · TERMINATED
Trial details
- NCT number
- NCT02240121
- Sponsor
- Bausch Health Americas, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-21
- Primary completion
- 2017-08-16
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.